Simplex Trading, LLC Celldex Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $2.98 Billion
- Q2 2024
A detailed history of Simplex Trading, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 8,600 shares of CLDX stock, worth $282,596. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,600
Previous 24,101
64.32%
Holding current value
$282,596
Previous $1.01 Million
68.55%
% of portfolio
0.01%
Previous 0.03%
Shares
19 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$265 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$123 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$111 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$109 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.54B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...